However, the outcome of HFpEF cannot be improved even with an angiotensin-converting-enzyme inhibitor, angiotensin receptor blocker, beta blocker, or aldosterone antagonist [57–60], all of which are effective for improving the outcome in heart failure with a reduced ejection fraction (HFrEF) [61]. This evidence concerns the gene ACE and heart failure.